Publication:
HIGH-DOSE EPIRUBICIN IN CHEMOTHERAPY REFRACTORY NONSEMINOMATOUS GERM-CELL CANCER - A PHASE-II STUDY

Thumbnail Image

Date

1992

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

KLUWER ACADEMIC PUBL

Research Projects

Organizational Units

Journal Issue

Abstract

Eighteen patients with progressive disseminated, platinum-resistant germ cell tumors were treated with epirubicin 35 mg/m2, every 3 weeks. One patient had stable disease, 17 developed progression. Myelosuppression was dose-limiting. One patient died of neutropenic septicemia. High-dose epirubicin is not active against platinum-resistant germ cell cancer.

Description

Keywords

EPIRUBICIN, GERM CELL CANCER, TESTICULAR CANCER, TESTICULAR CANCER

Citation

URI

https://hdl.handle.net/11424/263552

Collections

Araştırma Çıktıları

Endorsement

Review

Supplemented By

Referenced By